Search Results 951-960 of 18131 for monoclonal antibody

1. Mayo Clinic Q&A: Understanding myeloma treatment

   Myeloma is a cancer that affects specialized antibody-producing cells called plasma cells. Learn more from Mayo Clinic.

2. Study Of ABBV-383 Assessing Adverse Events And Clinical Activity With Subcutaneous (SC) Injection In Adult Participants With Relapsed Or Refractory Multiple Myeloma

   Serum monoclonal paraprotein (M-protein) level ... Subject has received BCMAxCD3 bispecific antibody. ... antibody (HBcAb) and hepatitis B surface antibody (HBsAb) ...

3. A Study Of Hematopoiesis In Patients With Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), And Healthy Controls - Mayo Clinic

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

4. Evaluating The Safety And Efficacy Of TLD In Patients With COPD - Mayo Clinic

   * Participant started taking a monoclonal antibody (mAb), or a PDE3/PDE4 inhibitor less than 6 months prior to screening. (Participants on these medications ...

5. Advancing a new era of regenerative medicine - Mayo Clinic News Network

   "Mayo Clinic has the clarity of vision to lead in this space. I'm grateful to be a part of it." ###. What's the latest on monoclonal antibody therapies to ...

6. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

   A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

7. Precision diagnosis of MOG antibody-associated disease is critical for timely, targeted therapy - Mayo Clinic

   Mayo Clinic offers the first coordinated, multidisciplinary clinic in the world that is devoted specifically to MOGAD, a rare antibody-mediated inflammatory ...

8. Recent COVID-19 infection could affect recommended timing of your COVID-19 vaccination - Mayo Clinic News Network

   You received convalescent plasma or monoclonal antibody in the last 90 days. Health care providers stress that getting vaccinated for COVID-19 is an ...

9. A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

   Relapse is defined per the consensus panel recommendations from the Sixth International Workshop on WM as reappearance of monoclonal IgM protein and/or ...

10. A Study Of ABBV-085, An Antibody Drug Conjugate, For Patients With Advanced Solid Cancer Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety and drug/body interactions of ABBV-085, and to determine the recommended future study dose (alone or in ...